Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong
· Delayed Price · Currency is HKD 24.14
+0.04 (0.17%)
Mar 10, 2026, 1:05 PM HKT
HKG:6826 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 9,810 | 10,169 | 13,346 | 17,596 | 16,428 | 23,247 | Upgrade
|
| Market Cap Growth | -24.27% | -23.81% | -24.15% | 7.11% | -29.33% | 40.30% | Upgrade
|
| Enterprise Value | 7,676 | 8,073 | 11,268 | 15,426 | 13,661 | 20,392 | Upgrade
|
| Last Close Price | 24.10 | 24.40 | 25.57 | 26.52 | 23.92 | 32.66 | Upgrade
|
| PE Ratio | 20.05 | 36.40 | 29.83 | 38.38 | 80.52 | 53.77 | Upgrade
|
| Forward PE | - | 11.00 | 10.73 | 12.54 | 12.85 | 13.24 | Upgrade
|
| PS Ratio | 3.56 | 3.70 | 4.68 | 6.06 | 6.91 | 10.82 | Upgrade
|
| PB Ratio | 1.50 | 1.55 | 2.12 | 2.65 | 2.46 | 3.13 | Upgrade
|
| P/TBV Ratio | 1.95 | 2.02 | 2.73 | 3.43 | 3.24 | 4.04 | Upgrade
|
| P/FCF Ratio | - | - | 44.10 | 43.30 | - | 265.24 | Upgrade
|
| P/OCF Ratio | - | - | 19.34 | 25.17 | 62.83 | 55.33 | Upgrade
|
| PEG Ratio | - | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | Upgrade
|
| EV/Sales Ratio | 2.79 | 2.93 | 3.95 | 5.31 | 5.75 | 9.49 | Upgrade
|
| EV/EBITDA Ratio | 17.35 | 18.25 | 19.29 | 24.77 | 35.23 | 50.04 | Upgrade
|
| EV/EBIT Ratio | 31.28 | 32.90 | 28.46 | 35.74 | 73.52 | 84.37 | Upgrade
|
| EV/FCF Ratio | - | - | 37.23 | 37.96 | - | 232.66 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.08 | 0.07 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 1.04 | 1.04 | 0.78 | 0.69 | 0.32 | 0.30 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.58 | 1.11 | - | 1.48 | Upgrade
|
| Net Debt / Equity Ratio | -0.37 | -0.37 | -0.39 | -0.39 | -0.41 | -0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.50 | -5.50 | -4.22 | -4.19 | -7.10 | -8.47 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -8.14 | -6.42 | 31.28 | -39.41 | Upgrade
|
| Asset Turnover | - | - | 0.38 | 0.38 | 0.30 | 0.26 | Upgrade
|
| Inventory Turnover | - | - | 1.66 | 1.56 | 1.56 | 1.61 | Upgrade
|
| Quick Ratio | - | - | 3.57 | 4.35 | 5.76 | 6.78 | Upgrade
|
| Current Ratio | - | - | 4.22 | 5.24 | 6.91 | 7.62 | Upgrade
|
| Return on Equity (ROE) | 4.25% | 4.25% | 6.30% | 6.92% | 3.18% | 5.89% | Upgrade
|
| Return on Assets (ROA) | - | - | 3.27% | 3.50% | 1.48% | 1.86% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.96% | 6.04% | 8.28% | 8.93% | 3.96% | 5.98% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 5.90% | 6.10% | 2.60% | 3.00% | Upgrade
|
| Earnings Yield | 2.85% | 2.75% | 3.35% | 2.60% | 1.24% | 1.86% | Upgrade
|
| FCF Yield | - | - | 2.27% | 2.31% | -0.54% | 0.38% | Upgrade
|
| Dividend Yield | 4.70% | - | 4.16% | 2.12% | 1.35% | 1.88% | Upgrade
|
| Payout Ratio | - | - | 61.80% | 16.46% | 67.54% | 24.96% | Upgrade
|
| Buyback Yield / Dilution | 0.50% | 0.30% | 1.77% | 30.24% | 1.46% | 0.62% | Upgrade
|
| Total Shareholder Return | 5.20% | 0.30% | 5.93% | 32.36% | 2.80% | 2.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.